The Health Information and Quality Authority (HIQA) has published a health technology assessment (HTA) recommending the introduction of a metabolic surgery programme as part of the clinical pathway for type 2 diabetes in Ireland. HIQA undertook this HTA at the request of the HSE.
Bariatric surgery involves changing how the stomach and small intestine process food, resulting in weight loss and improvements in obesity-related health complications. Traditionally, it is used as a weight-loss intervention in patients with obesity. The term metabolic surgery refers to the use of bariatric surgery procedures with the aim of improving type 2 diabetes control in patients with comorbid (both) type 2 diabetes and obesity.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
